Scientists and startups are clamoring to research CBD, a compound in marijuana that doesn't get you high — here are its potential benefits

Business Insider | 4/25/2018 | Erin Brodwin
moricamorica (Posted by) Level 3
Click For Photo:

CBD, or cannabidiol, is a non-psychoactive component of cannabis that won't get you high.

Researchers are beginning to study its potential health applications, which range from pain relief to curbing certain types of epileptic seizures.

Scientists - Startups - Drugs - Hole - CBD

Scientists and startups working on cannabis-based drugs say the biggest hole in CBD research has to do with dosing — so they're tackling that first.

I knew I'd arrived in California when a friend offered me an edible — for my dog.

Treat - THC - Component - Marijuana - Cannabidiol

The treat didn't contain THC, the component of marijuana that's responsible for getting you high. Instead, it was made with cannabidiol, or CBD, a non-psychoactive compound in cannabis.

CBD is thought to be responsible for many of marijuana's therapeutic effects, including pain relief and reducing inflammation or swelling. Because of that, the compound may have a range of therapeutic applications, but research on it remains in its infancy — mostly due to marijuana's status as a Schedule I drug in the US, which limits the scope of medical research on it.

Thanks - Wave - Developments - Drugs - Efforts

Thanks to a wave of developments into new cannabis-based drugs, however, efforts to harness CBD's medicinal properties are likely to ramp up.

The most well documented application of CBD so far is as a potential treatment for some rare forms of epilepsy. Earlier this month, a US Food and Drug Administration committee gave a major green light to a medicine called Epidiolex, which is designed to treat two rare childhood forms of epilepsy. If Epidiolex gets the final okay, it would become the first FDA-approved drug made with CBD.

Drug - Companies - GW - Pharmaceuticals - Epidiolex

Drug companies like GW Pharmaceuticals, which is behind Epidiolex, and a handful of startups — some of which have support from pharma giants like Johnson & Johnson — are now finding ways to study CBD. Researchers are looking into applications for mental health disorders like anxiety and depression, skin conditions, and...
(Excerpt) Read more at: Business Insider
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!